In this Spotlight interview, Franklin Spriggs (KCAS; KS, USA) explains his interest in biomarkers and introduces the technologies and techniques utilized and offered by KCAS.
Find out more about the current situation for biomarker research in Japan in this Editorial from Bioanalysis.
Read more about the top stories in biomarker developments in this week’s news round-up.
Accurate and precise biomarker measurement is critical to identifying diagnostic markers and druggable targets. Learn how quantitative mass spectrometry ensures proper biomarker measurement and characterization.
In this podcast, Kevin Ray (MilliporeSigma) discusses the techniques and technologies utilized in drug metabolism studies for biotherapeutics, and what he believes the future holds for the field.
Considerations for developing and validating an LC–MS biomarker assay using the surrogate peptide approach
In this editorial, Timothy Sikorski (GSK; PA, USA), discusses particular considerations for developing and validating LC–MS biomarker assays using the surrogate peptide approach.
Definitive profiling of plasma bile acids as potential biomarkers for human liver diseases using UPLC–HRMS
Find out more about this investigation into a thorough and rapid profiling of bile acids in human plasma in this article from Bioanalysis.
Challenged to remove matrix interferences while dealing with the evolving complexity of biotherapeutics? This presentation illustrates how SelexION+ DMS can be efficiently utilized to overcome background interference challenges, which might otherwise limit assay capabilities.
Find out more about the co-development agreement between Xbrane and STADA for a ranibizumab biosimilar, and about a novel biomarker test for establishing lung cancer risk in smokers in this week’s bioanalytical news round-up.
Find out more about the consequences of utilizing biomarker assays in drug development without being validated correctly, in this Perspective from Bioanalysis.